Disclosed is the use of a compound of formula (I), wherein said compound is 1-(4-thio-beta-D-arabinofuranosyl) cytosine or 1-(4-thio-beta-D-arabinofuranosyl) fluorocytosine, in the manufacture of a medicine for the treatment or prevention of arthritis.